Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
133.11
+2.05 (1.56%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of $14.74 billion as of March 28, 2024. Its market cap has decreased by -1.45% in one year.
Market Cap
14.74B
Enterprise Value
19.42B
1-Year Change
-1.45%
Ranking
Category
Stock Price
$133.11
Market Cap Chart
Since December 1, 1998, Quest Diagnostics's market cap has increased from $531.80M to $14.74B, an increase of 2,671.01%. That is a compound annual growth rate of 14.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 14.74B | 1.56% |
Mar 27, 2024 | 14.51B | 1.70% |
Mar 26, 2024 | 14.27B | -0.32% |
Mar 25, 2024 | 14.31B | -0.02% |
Mar 22, 2024 | 14.31B | 0.37% |
Mar 21, 2024 | 14.26B | 0.87% |
Mar 20, 2024 | 14.14B | -1.04% |
Mar 19, 2024 | 14.29B | 0.72% |
Mar 18, 2024 | 14.19B | -0.11% |
Mar 15, 2024 | 14.20B | 0.91% |
Mar 14, 2024 | 14.07B | -1.77% |
Mar 13, 2024 | 14.33B | -0.25% |
Mar 12, 2024 | 14.36B | 0.24% |
Mar 11, 2024 | 14.33B | 1.72% |
Mar 8, 2024 | 14.09B | -0.12% |
Mar 7, 2024 | 14.10B | 0.37% |
Mar 6, 2024 | 14.05B | 1.94% |
Mar 5, 2024 | 13.78B | -0.64% |
Mar 4, 2024 | 13.87B | 0.50% |
Mar 1, 2024 | 13.80B | -0.17% |
Feb 29, 2024 | 13.83B | -0.61% |
Feb 28, 2024 | 13.91B | -0.61% |
Feb 27, 2024 | 14.00B | 0.18% |
Feb 26, 2024 | 13.97B | -0.69% |
Feb 23, 2024 | 14.07B | 1.39% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hologic | 18.16B |
Walgreens Boots Alliance | 18.15B |
BeiGene | 17.01B |
BioMarin Pharmaceutical | 16.72B |
Teva Pharmaceutical | 16.09B |
Viatris | 13.96B |
Charles River Laboratories International | 13.83B |
Neurocrine Biosciences | 13.72B |